Minoxidil use in dermatology, side effects and recent patents.
Level 5 - mechanism / opinion, no new human data
Narrative review of literature and patents without systematic methodology or primary data
PubMed 22409453 · doi:10.2174/187221312800166859
What was done
This narrative review summarizes the mechanism of action, clinical use in dermatology (specifically female and male androgenic alopecia), adverse effect profile, and recent patents addressing formulation-related side effects of topical minoxidil.
What was found
The abstract reports no numerical data or quantitative outcomes. It describes that topical minoxidil (2% for females, 5% for males) requires once- or twice-daily application to maintain hair gains, with benefits reversing within months of cessation. Reported side effects include temporary initial hair shedding due to hair cycle synchronization, as well as irritant and allergic contact dermatitis, often attributable to the excipient propylene glycol.
Why it matters
It provides an overview of minoxidil's practical management considerations, highlighting that adverse scalp reactions are frequently driven by vehicle ingredients rather than minoxidil itself.
Limits
This is a non-systematic narrative review providing no primary clinical data, quantitative effect estimates, or pooled risk figures in the abstract. Methodological search criteria and quality assessments are absent.
Cited by
- supports Minoxidil functions as a potassium channel opener and when taken orally can cause pericardial effusion, water retention, and electrolyte dysregulation.